Meng Z, Zhang R, Sun Z, Fu C, Li Z, Wang L, Huo R, Xue F. Hotspots and future trends of dermatofibrosarcoma protuberans.
Front Oncol 2024;
14:1399486. [PMID:
39600645 PMCID:
PMC11588712 DOI:
10.3389/fonc.2024.1399486]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2024] [Accepted: 10/15/2024] [Indexed: 11/29/2024] Open
Abstract
Objective
Dermatofibrosarcoma protuberans (DFSP) is a moderately malignant soft tissue sarcoma with localized infiltrative growth. The extensive surgical scope and high recurrence rate of DFSP brings dysfunctional, aesthetic, psychological and economic problems to patients. The aim of this study is to explore the global publication characteristics, research hotspots and future trends of DFSP over the past 32 years via an intuitive visualized way.
Methods
The Web of Science Core Collection (WoSCC) database was searched for papers related to DFSP published from 1990 to 2022. Then bibliometric analysis of these publications was performed, including collaborative networks, co-citation analysis of journals and references, and cluster analysis of keywords.
Results
A total of 1588 papers were retrieved between 1990-2022. The United States was the most prolific country, followed by China. The article Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials, received most citations. Research hotspots and future trends are mainly focused on disease diagnosis, COL1A1-PDGFB fusion gene, drug and surgical treatment, fibrosarcomatous transformation, and immunotherapy.
Conclusion
The research on DFSP faces several clinical challenges. This study provides novel insights into future research directions and scientific decisions for DFSP.
Collapse